ABT

SEC source: 0001104659-07-049398 · a4.xml · nonDerivative · entry 5

Patton Donald V JR · CIK 0001396490 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,299

SEC source: 0001104659-07-049398 · a4.xml · nonDerivative · entry 4

Patton Donald V JR · CIK 0001396490 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,208

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-07-049398 · a4.xml · nonDerivative · entry 3

Patton Donald V JR · CIK 0001396490 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,568

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-07-049398 · a4.xml · nonDerivative · entry 2

Patton Donald V JR · CIK 0001396490 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,806

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-07-049398 · a4.xml · nonDerivative · entry 1

Patton Donald V JR · CIK 0001396490 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,885

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-07-049430 · a4.xml · derivative · entry 6

SMITHBURG WILLIAM D · CIK 0001190304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: common shares · 777 shares

Expires 2007-06-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program.

SEC source: 0001104659-07-049430 · a4.xml · derivative · entry 5

SMITHBURG WILLIAM D · CIK 0001190304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: common shares · 777 shares

Expires 2007-09-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program.

SEC source: 0001104659-07-049430 · a4.xml · derivative · entry 4

SMITHBURG WILLIAM D · CIK 0001190304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: common shares · 1,557 shares

Expires 2007-10-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program.

SEC source: 0001104659-07-049430 · a4.xml · nonDerivative · entry 2

SMITHBURG WILLIAM D · CIK 0001190304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,391

SEC source: 0001104659-07-049430 · a4.xml · nonDerivative · entry 1

SMITHBURG WILLIAM D · CIK 0001190304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,127

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-07-044919 · a4.xml · nonDerivative · entry 1

Fussell Stephen R · CIK 0001327700 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,136

SEC source: 0001104659-07-045248 · a4.xml · derivative · entry 16

Tyree James L · CIK 0001324991 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: common shares · 9,217 shares

Expires 2008-02-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.

SEC source: 0001104659-07-045248 · a4.xml · derivative · entry 15

Tyree James L · CIK 0001324991 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: common shares · 4,549 shares

Expires 2008-02-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.

SEC source: 0001104659-07-045248 · a4.xml · derivative · entry 14

Tyree James L · CIK 0001324991 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: common shares · 8,422 shares

Expires 2007-12-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.

SEC source: 0001104659-07-045248 · a4.xml · derivative · entry 13

Tyree James L · CIK 0001324991 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: common shares · 3,958 shares

Expires 2007-12-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.

SEC source: 0001104659-07-045248 · a4.xml · derivative · entry 12

Tyree James L · CIK 0001324991 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: common shares · 153 shares

Expires 2007-06-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.

SEC source: 0001104659-07-045248 · a4.xml · derivative · entry 11

Tyree James L · CIK 0001324991 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: common shares · 2,429 shares

Expires 2007-06-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.

SEC source: 0001104659-07-045248 · a4.xml · derivative · entry 10

Tyree James L · CIK 0001324991 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: common shares · 6,069 shares

Expires 2007-06-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.

SEC source: 0001104659-07-045248 · a4.xml · nonDerivative · entry 8

Tyree James L · CIK 0001324991 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 106,597

SEC source: 0001104659-07-045248 · a4.xml · nonDerivative · entry 7

Tyree James L · CIK 0001324991 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 119,930

SEC source: 0001104659-07-045248 · a4.xml · nonDerivative · entry 6

Tyree James L · CIK 0001324991 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 154,727

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-07-045248 · a4.xml · nonDerivative · entry 5

Tyree James L · CIK 0001324991 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 145,510

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-07-045248 · a4.xml · nonDerivative · entry 4

Tyree James L · CIK 0001324991 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 140,961

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-07-045248 · a4.xml · nonDerivative · entry 3

Tyree James L · CIK 0001324991 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 137,003

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-07-045248 · a4.xml · nonDerivative · entry 2

Tyree James L · CIK 0001324991 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 136,850

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-07-045248 · a4.xml · nonDerivative · entry 1

Tyree James L · CIK 0001324991 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 134,421

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-07-044338 · a4.xml · nonDerivative · entry 1

SCOTT SAMUEL C III · CIK 0001202862 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,730

SEC source: 0001104659-07-043032 · a4.xml · derivative · entry 3

Schumacher Laura J · CIK 0001319245 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: common shares · 844 shares

Expires 2007-06-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.

SEC source: 0001104659-07-043032 · a4.xml · nonDerivative · entry 1

Schumacher Laura J · CIK 0001319245 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 117,524

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001104659-07-041000 · a4.xml · nonDerivative · entry 1

Chen Thomas F · CIK 0001360147 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,874

SEC source: 0001104659-07-034476 · a4.xml · nonDerivative · entry 1

Tyree James L · CIK 0001324991 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 119,930

SEC source: 0001104659-07-034470 · a4.xml · nonDerivative · entry 1

AUSTIN ROXANNE S · CIK 0001061632 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,590

F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program).

F1 · price: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001104659-07-034471 · a4.xml · nonDerivative · entry 1

DALEY WILLIAM M · CIK 0001183865 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,246

F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program).

F1 · price: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001104659-07-034472 · a4.xml · nonDerivative · entry 1

POWELL BOONE JR · CIK 0001232973 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,775

F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the board, dies, or the occurrence of a change in control (as defined in the Program).

F1 · price: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the board, dies, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001104659-07-034474 · a4.xml · nonDerivative · entry 1

ROBERTS ROY S · CIK 0001200813 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,238

F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the board, dies, or the occurrence of a change in control (as defined in the Program).

F1 · price: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the board, dies, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001104659-07-034473 · a4.xml · nonDerivative · entry 1

REYNOLDS W ANN · CIK 0001018652 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,732

F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the board, dies, or the occurrence of a change in control (as defined in the Program).

F1 · price: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the board, dies, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001104659-07-034477 · a4.xml · nonDerivative · entry 1

OWEN DAVID · CIK 0001239142 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,266

F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the board, dies, or the occurrence of a change in control (as defined in the Program).

F1 · price: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the board, dies, or the occurrence of a change in control (as defined in the Program).

F2 · balance_after: Includes shares acquired under the Abbott Laboratories Dividend Reinvestment and Stock Purchase Plan. These transactions are exempt from Section 16 under Rule 16a-11.

SEC source: 0001104659-07-034480 · a4.xml · nonDerivative · entry 1

SCOTT SAMUEL C III · CIK 0001202862 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,730

F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001104659-07-034486 · a4.xml · nonDerivative · entry 1

FULLER H LAURANCE · CIK 0001187553 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,380

F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program).

F1 · price: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001104659-07-034483 · a4.xml · nonDerivative · entry 1

FARRELL W JAMES · CIK 0001021872 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,857

F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001104659-07-034484 · a4.xml · nonDerivative · entry 1

SMITHBURG WILLIAM D · CIK 0001190304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,016

F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the board, dies, or the occurrence of a change in control (as defined in the Program).

F1 · price: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the board, dies, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001104659-07-034490 · a4.xml · nonDerivative · entry 1

TILTON GLENN F · CIK 0001194624 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,340

F1 · kind: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the Board, dies, or the occurrence of a change in control (as defined in the Program).

SEC source: 0001104659-07-031466 · a4.xml · nonDerivative · entry 1

Chen Thomas F · CIK 0001360147 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,874

SEC source: 0001104659-07-061065 · a4.xml · nonDerivative · entry 1

Bohuon Olivier · CIK 0001360215 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,664

F1 · kind: Settlement of a performance-based restricted stock unit in shares in a transaction exempt from Section 16(b) under Rule 16b-3.

SEC source: 0001104659-07-029050 · a4.xml · derivative · entry 4

Patton Donald V JR · CIK 0001396490 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,300

Underlying: common shares · 47,300 shares

Expires 2017-04-15

F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 15,767 on 4/16/2008, 15,767 on 4/16/09, and 15,766 on 4/16/10.

SEC source: 0001104659-07-029050 · a4.xml · nonDerivative · entry 2

Patton Donald V JR · CIK 0001396490 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,107

F2 · kind: These shares represent a retention award of restricted stock under the Abbott Laboratories 1996 Incentive Stock Program. The awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes.

SEC source: 0001104659-07-029050 · a4.xml · nonDerivative · entry 1

Patton Donald V JR · CIK 0001396490 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,107

F1 · kind: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.

SEC source: 0001104659-07-025425 · a4.xml · derivative · entry 1

POWELL BOONE JR · CIK 0001232973 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,481

Underlying: common shares · 224 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

SEC source: 0001104659-07-025418 · a4.xml · nonDerivative · entry 1

LIEPMANN HOLGER A · CIK 0001283517 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 143,507

SEC source: 0001104659-07-025426 · a4.xml · derivative · entry 1

SMITHBURG WILLIAM D · CIK 0001190304 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,753

Underlying: common shares · 439 shares

Expires not disclosed

F1 · derivative.exercise_price: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.exercise_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F1 · derivative.expiration_date: Director fees deferred and credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott stock.

F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.